Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA.
J Urol. 2012 Apr;187(4):1228-33. doi: 10.1016/j.juro.2011.11.086. Epub 2012 Feb 14.
There are scant data available on the relationship between smoking and total prostate specific antigen, free prostate specific antigen and percent-free prostate specific antigen. Given the high prevalence of smoking and the frequency of prostate specific antigen screening, it is important to determine any association between smoking and prostate specific antigen values using nationally representative data.
Included in the final study population were 3,820 men 40 years old or older who participated in the 2001-2006 NHANES (National Health and Nutrition Examination Survey) and met the eligibility criteria for prostate specific antigen testing. The distributions of total, free and percent free prostate specific antigen were estimated by sociodemographic and clinical characteristics. Multivariate linear regression models were fit to determine the adjusted relationship between smoking and total and percent free prostate specific antigen while simultaneously controlling for these characteristics.
For all ages combined the median total and free prostate specific antigen levels were 0.90 (0.81-0.90) and 0.26 (0.25-0.28) ng/ml, respectively. Multivariate linear regression analysis showed that total prostate specific antigen was 7.9% and 12.2% lower among current and former smokers, respectively, than among never smokers. High body mass index and diabetes were also statistically significantly associated with a lower total prostate specific antigen. Approximately a third of the men had a percent free prostate specific antigen less than 25%. Current smokers had a significantly lower percent free prostate specific antigen than former smokers.
Our finding that smoking is inversely associated with total prostate specific antigen may have potential implications for the interpretation of prostate specific antigen levels in men who are current or former smokers. Given the high prevalence of smoking, obesity and diabetes, additional research on the combined effect of these health risk factors is warranted.
有关吸烟与总前列腺特异性抗原、游离前列腺特异性抗原和游离前列腺特异性抗原百分比之间关系的数据很少。鉴于吸烟的高患病率和前列腺特异性抗原筛查的频率,使用全国代表性数据确定吸烟与前列腺特异性抗原值之间的任何关联非常重要。
最终研究人群包括 3820 名年龄在 40 岁或以上的男性,他们参加了 2001-2006 年 NHANES(国家健康和营养检查调查),并且符合前列腺特异性抗原检测的资格标准。根据社会人口统计学和临床特征估计总前列腺特异性抗原、游离前列腺特异性抗原和游离前列腺特异性抗原百分比的分布。拟合多变量线性回归模型,以确定吸烟与总前列腺特异性抗原和游离前列腺特异性抗原百分比之间的调整关系,同时控制这些特征。
对于所有年龄组,总前列腺特异性抗原和游离前列腺特异性抗原的中位数分别为 0.90(0.81-0.90)和 0.26(0.25-0.28)ng/ml。多变量线性回归分析表明,与从不吸烟者相比,当前吸烟者和前吸烟者的总前列腺特异性抗原分别低 7.9%和 12.2%。高体重指数和糖尿病也与总前列腺特异性抗原降低具有统计学显著相关性。大约三分之一的男性游离前列腺特异性抗原百分比小于 25%。与前吸烟者相比,当前吸烟者的游离前列腺特异性抗原百分比显著降低。
我们发现吸烟与总前列腺特异性抗原呈负相关,这可能对解释当前或前吸烟者的前列腺特异性抗原水平具有潜在意义。鉴于吸烟、肥胖和糖尿病的高患病率,需要进一步研究这些健康风险因素的综合影响。